; and (2) not later than 1 year after the date of enactment of this Act, finalize such strategy. (b) Considerations When developing the national strategy under subsection (a), the Secretaries concerned shall consider— (1) the best available science related to products with the characteristics of animal meat using plants, animal cell cultivation, and fermentation; (2) the societal benefits of expanding research, development, and production of alternative proteins relating to— (A) personal and public health; (B) climate change and energy; (C) food and agricultural innovation; (D) resilient supply chains; and (E) cross-cutting scientific advancements; (3) global competition and the economic benefits of alternative proteins relating to— (A) future economic productivity; (B) job creation in the biotechnology sector; and (C) existing public investments and strategies of competitor countries; and (4) existing policies and programs offered by the Federal and State governments that— (A) fund open-access research and development at higher-learning institutions and government agencies; (B) incentivize private sector research and development; (C) support new and existing alternative protein producers and manufacturers; (D) support farmers in the United States that produce outputs related to alternative proteins; and (E) represent a barrier for effective— (i) open-access alternative protein research and development; (ii) scale-up of alternative protein production and manufacturing; and (iii) regulatory oversight. (c) Contents The national strategy shall— (1) use a whole-of-government approach to ensure that the United States remains the global leader of alternative protein research, development, production, and workforce development for future generations; and (2) include— (A) objectives to fulfill the purpose of the national strategy specified in paragraph (1), including interagency coordination; (B) barriers to fulfill such purpose; (C) solutions to the barriers identified in subsection (b)(4)(E)